Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 1087

 Table of Contents  
Year : 2011  |  Volume : 3  |  Issue : 5  |  Page : 227-233

E-Cadherin as a diagnostic biomarker in breast cancer

1 Department of Biochemistry, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, India
2 Department of General Surgery, Seth G. S. Medical College and K.E.M. Hospital, Parel, Mumbai, India
3 Department of General Surgery, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, India
4 Department of General Surgery, Government Medical College, Miraj, Maharashtra, India

Date of Web Publication9-Nov-2011

Correspondence Address:
Rajeev Singhai
C-505, Beach Classic CHS Ltd, Near Gorai Pumping Station, Chikoowadi, Borivali (W), Mumbai-400092
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 22558599

Rights and PermissionsRights and Permissions

Background: E-cadherin is expressed in most normal epithelial tissues. Selective loss of E-cadherin can cause dedifferentiation and invasiveness in human carcinomas, leading E-cadherin to be classified as a tumor suppressor. Loss of E-cadherin has been demonstrated in invasive lobular carcinoma of the breast, but the relationship between E-cadherin expression and breast cancer histopathology and prognosis is less clear. Aim: Our objective was to assess loss of E-cadherin as a diagnostic breast cancer biomarker and as an aid to the sub-classification of invasive breast cancer. We also correlated the loss of expression of E-cadherin with various clinical and pathologic prognostic factors. Material and Methods: Breast cancer specimens after modified radical mastectomy were obtained from women who underwent surgery at Grant Medical College and Sir J.J Group of Hospitals, Mumbai, India between May 2007 and October 2010. We stained 276 breast cancers specimens with monoclonal antibodies to E-cadherin. The breast cancers were classified by histopathological type. Results: A statistical correlation of E-cadherin loss with a positive diagnosis of invasive lobular carcinoma was found, but there was no correlation with any prognostic tumor variables. A negative E-cadherin stain was a sensitive and specific biomarker to confirm the diagnosis of invasive lobular carcinoma (specificity 97.7%; negative predictive value 96.8%; sensitivity 88.1%; and positive predictive value 91.2%). Positive E-cadherin expression was also associated with tubulolobular carcinomas. Conclusions: E-cadherin immunohistochemistry is helpful in classifying breast cancer cases with indeterminate histopathologic features. E-cadherin loss is uncommon in non-lobular carcinomas but shows no correlation to currently established prognostic variables.

Keywords: Breast cancer, E-Cadherin, prognostic cancer tissue biomarkers, invasive lobular carcinomas, invasive ductal carcinoma, tubulolobular carcinoma, invasive carcinoma.

How to cite this article:
Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV. E-Cadherin as a diagnostic biomarker in breast cancer. North Am J Med Sci 2011;3:227-33

How to cite this URL:
Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV. E-Cadherin as a diagnostic biomarker in breast cancer. North Am J Med Sci [serial online] 2011 [cited 2023 Jun 5];3:227-33. Available from: https://www.najms.org/text.asp?2011/3/5/227/86169

The article found to be Plagiarized and hence been Retracted.

This article has been cited by
1 Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype
Senkus, E. and Szade, J. and Pieczyńska, B. and Zaczek, A. and Brozek, I. and Radecka, B. and Kowalczyk, A. and Wełnicka-Jaśkiewicz, M. and Jassem, J.
Breast. 2013; 22(4): 425-430
2 Effect of low dose bisphenol A on the early differentiation of human embryonic stem cells into mammary epithelial cells
Yang, L. and Luo, L. and Ji, W. and Gong, C. and Wu, D. and Huang, H. and Liu, Q. and Xia, B. and Hu, G. and Zhang, W. and Zhang, Q. and Liu, J. and Zhang, W. and Zhuang, Z.
Toxicology Letters. 2013; 218(3): 187-193
3 Functional analysis of human cancer-associated genes and their association with the testes and epididymis
Hua, X.-F. and Wang, X.-B. and Liu, F.-J.
Oncology Letters. 2013; 6(3): 811-816
4 Association between E-cadherin gene promoter C-160A SNP and susceptibility to gastric cancer
Zhao, Y. and Xu, F. and Ren, H. and Zhang, Y.-F. and Li, X.-J.
Journal of Xian Jiaotong University (Medical Sciences). 2013; 34(2): 214-217
5 Effects of Musca domestica cecropin on the adhesion and migration of human hepatocellular carcinoma BEL-7402 cells
Jin, X.-B. and Mei, H.-F. and Pu, Q.-H. and Shen, J. and Lu, X.-M. and Chu, F.-J. and Zhu, J.-Y.
Biological and Pharmaceutical Bulletin. 2013; 36(6): 938-943
6 E-Cadherin expression: A diagnostic utility for differentiating breast carcinomas with ductal and lobular morphologies
Pai, K. and Baliga, P. and Lal Shrestha, B.
Journal of Clinical and Diagnostic Research. 2013; 7(5): 840-844
7 The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis
Jung, S.P. and Kim, S. and Nam, S.J. and Kim, I. and Bae, J.W.
Journal of Breast Cancer. 2013; 16(1): 16-22
8 Understanding the Role of Keratins 8 and 18 in Neoplastic Potential of Breast Cancer Derived Cell Lines
Iyer, S.V. and Dange, P.P. and Alam, H. and Sawant, S.S. and Ingle, A.D. and Borges, A.M. and Shirsat, N.V. and Dalal, S.N. and Vaidya, M.M.
PLoS ONE. 2013; 8(1)


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded270    
    Comments [Add]    
    Cited by others 8    

Recommend this journal